These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2848167)

  • 1. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.
    Abbott FV; Palmour RM
    Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
    Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 1998 Nov; 140(1):91-7. PubMed ID: 9862407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
    van Dorp EL; Kest B; Kowalczyk WJ; Morariu AM; Waxman AR; Arout CA; Dahan A; Sarton EY
    Anesthesiology; 2009 Jun; 110(6):1356-63. PubMed ID: 19461298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
    Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
    Faura CC; Olaso JM; Cabanes CG; Horga JF
    Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats.
    South SM; Smith MT
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1326-32. PubMed ID: 9732396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
    Doyle HH; Murphy AZ
    Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide.
    Hashiguchi Y; Molina PE; Abumrad NN
    Brain Res Bull; 1995; 38(4):325-9. PubMed ID: 8535854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine metabolites on micturition in normal, unanaesthetized rats.
    Igawa Y; Westerling D; Mattiasson A; Andersson KE
    Br J Pharmacol; 1993 Sep; 110(1):257-62. PubMed ID: 8220887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-6 beta-glucuronide induces potent immunomodulation.
    Carrigan KA; Lysle DT
    Int Immunopharmacol; 2001 May; 1(5):821-31. PubMed ID: 11379038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
    van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells.
    Baker L; Dye A; Ratka A
    Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat.
    Sullivan AF; McQuay HJ; Bailey D; Dickenson AH
    Brain Res; 1989 Mar; 482(2):219-24. PubMed ID: 2706485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
    Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
    Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
    Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
    J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
    Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral opioid analgesia in experimental human pain models.
    Tegeder I; Meier S; Burian M; Schmidt H; Geisslinger G; Lötsch J
    Brain; 2003 May; 126(Pt 5):1092-102. PubMed ID: 12690049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.